205 related articles for article (PubMed ID: 26894634)
1. European experience with methotrexate treatment in Crohn's disease: a multicenter retrospective analysis.
Kopylov U; Katsanos KH; van der Woude CJ; Karmiris K; Hernandez V; Odes S; Papamichael K; Koutroubakis IE; Bojic D; Kaimakliotis I; Fiorino G; Papageorgiou N; Pineda JR; Strongili K; Sanroman L; Mantzaris GJ; Jojic N; Paspatis G; Christodoulou DK; Ben-Horin S; Tsianos EV
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):802-6. PubMed ID: 26894634
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study.
Haisma SM; Lijftogt T; Kindermann A; Damen G; de Ridder L; Escher JC; Mearin ML; de Meij T; Hendriks D; George E; Hummel T; Norbruis O; van Rheenen P
J Crohns Colitis; 2015 Apr; 9(4):305-11. PubMed ID: 25656249
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study.
Uhlen S; Belbouab R; Narebski K; Goulet O; Schmitz J; Cézard JP; Turck D; Ruemmele FM
Inflamm Bowel Dis; 2006 Nov; 12(11):1053-7. PubMed ID: 17075346
[TBL] [Abstract][Full Text] [Related]
4. Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice.
Domènech E; Mañosa M; Navarro M; Masnou H; Garcia-Planella E; Zabana Y; Cabré E; Gassull MA
J Clin Gastroenterol; 2008 Apr; 42(4):395-9. PubMed ID: 18277899
[TBL] [Abstract][Full Text] [Related]
5. Retrospective cohort study of methotrexate use in the treatment of pediatric Crohn's disease.
Sunseri W; Hyams JS; Lerer T; Mack DR; Griffiths AM; Otley AR; Rosh JR; Carvalho R; Grossman AB; Cabrera J; Pfefferkorn MD; Rick J; Leleiko NS; Hitch MC; Oliva-Hemker M; Saeed SA; Kappelman M; Markowitz J; Keljo DJ;
Inflamm Bowel Dis; 2014 Aug; 20(8):1341-5. PubMed ID: 24983976
[TBL] [Abstract][Full Text] [Related]
6. Use of methotrexate in refractory Crohn's disease: the Edinburgh experience.
Din S; Dahele A; Fennel J; Aitken S; Shand AG; Arnott ID; Satsangi J
Inflamm Bowel Dis; 2008 Jun; 14(6):756-62. PubMed ID: 18275071
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of methotrexate therapy for refractory Crohn's disease: a large single-centre experience.
Suares NC; Hamlin PJ; Greer DP; Warren L; Clark T; Ford AC
Aliment Pharmacol Ther; 2012 Jan; 35(2):284-91. PubMed ID: 22112005
[TBL] [Abstract][Full Text] [Related]
8. [The efficacy and safety of methotrexate in refractory Crohn's disease].
Xu P; He Y; Chen Y; Chao K; Chen B; Mao R; Tang R; Zhu Z; Zeng Z; Chen M
Zhonghua Nei Ke Za Zhi; 2014 Mar; 53(3):188-92. PubMed ID: 24767205
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
Charpignon C; Beau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):153-7. PubMed ID: 18343615
[TBL] [Abstract][Full Text] [Related]
10. Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registry.
Salazar J; Garcia-Planella E; Fernández-Clotet A; Esteve M; Gisbert JP; Busquets D; Lucendo A; Márquez L; Guardiola J; Martín-Arranz MD; Iglesias E; Monfort D; Villoria A; Cañete F; Bell O; Ricart E; Zabana Y; Chaparro M; Domènech E; Gordillo J;
Br J Clin Pharmacol; 2024 May; 90(5):1301-1311. PubMed ID: 38369687
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate for maintenance of remission in chronic active Crohn's disease: long-term single-center experience and meta-analysis of observational studies.
Hausmann J; Zabel K; Herrmann E; Schröder O
Inflamm Bowel Dis; 2010 Jul; 16(7):1195-202. PubMed ID: 19924799
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic role of methotrexate in pediatric Crohn's disease.
Djurić Z; Šaranac L; Budić I; Pavlović V; Djordjević J
Bosn J Basic Med Sci; 2018 Aug; 18(3):211-216. PubMed ID: 29338679
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate for Refractory Crohn's Disease Compared with Thiopurines: A Retrospective Non-head-to-head Controlled Study.
Huang Z; Chao K; Li M; Zhi M; Tang J; Hu P; Gao X
Inflamm Bowel Dis; 2017 Mar; 23(3):440-447. PubMed ID: 28129286
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: a large single centre experience.
Sprakes MB; Ford AC; Warren L; Greer D; Hamlin J
J Crohns Colitis; 2012 Mar; 6(2):143-53. PubMed ID: 22325168
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients.
Rouiller-Braunschweig C; Fournier N; Pittet V; Dudler J; Michetti P
Digestion; 2017 Nov; 96(4):220-227. PubMed ID: 29065423
[TBL] [Abstract][Full Text] [Related]
16. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
Nathan DM; Iser JH; Gibson PR
J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
[TBL] [Abstract][Full Text] [Related]
17. Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course.
Harris RE; Aloi M; de Ridder L; Croft NM; Koletzko S; Levine A; Turner D; Veereman G; Neyt M; Bigot L; Ruemmele FM; Russell RK;
BMJ Open; 2020 Jul; 10(7):e034892. PubMed ID: 32611737
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
Weiss B; Lerner A; Shapiro R; Broide E; Levine A; Fradkin A; Bujanover Y
J Pediatr Gastroenterol Nutr; 2009 May; 48(5):526-30. PubMed ID: 19412004
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate is an efficient therapeutic alternative in children with thiopurine-resistant Crohn's disease.
Hojsak I; Mišak Z; Jadrešin O; Močić Pavić A; Kolaček S
Scand J Gastroenterol; 2015; 50(10):1208-13. PubMed ID: 25877164
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of oral methotrexate in paediatric Crohn's disease: a multicentre propensity score study.
Turner D; Doveh E; Cohen A; Wilson ML; Grossman AB; Rosh JR; Lu Y; Bousvaros A; Deslandres C; Noble A; Baldassano RN; Levine A; Lerner A; Wilson DC; Griffiths AM
Gut; 2015 Dec; 64(12):1898-904. PubMed ID: 25416066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
